3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Unknown
1
Terminated
1
Recruiting
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Dermatologic
1
Conditions
Melanoma
7
Neoplasm Metastasis
5
Carcinoma, Non-Small-Cell Lung
5
Stomach Neoplasms
4
Ovarian Neoplasms
4
Breast Neoplasms
4
Uterine Cervical Neoplasms
3
Skin Neoplasms
3
Pancreatic Neoplasms
3
Multiple Myeloma
3
Lung Neoplasms
3
Leukemia, Myeloid, Acute
3
Carcinoma, Renal Cell
3
Vulvar Neoplasms
2
Vaginal Neoplasms
2
Urogenital Neoplasms
2
Triple Negative Breast Neoplasms
2
Pleural Effusion, Malignant
2
Penile Neoplasms
2
Oropharyngeal Neoplasms
2
Neuroblastoma
2
Myelodysplastic Syndromes
2
Mesothelioma, Malignant
2
Leukemia, Myeloid
2
Leukemia
2
Hematologic Neoplasms
2
Carcinoma, Merkel Cell
2
Anus Neoplasms
2
Uveal Melanoma
1
Urinary Bladder Neoplasms
1
Interventions
tebentafusp
4
Nivolumab
4
Magnetic Resonance Spectroscopy
3
Cyclophosphamide
3
pembrolizumab
2
fludarabine phosphate
2
fludarabine
2
cemiplimab
2
Specimen Handling
2
Ipilimumab
2
Interleukin-2
2
sargramostim
1
quisinostat
1
olaparib
1
lifileucel
1
binimetinib
1
aldesleukin
1
aflibercept
1
Valproic Acid
1
Spinal Puncture
1
Protein Kinase C
1
Melatonin
1
Interleukin-13
1
Hematologic Tests
1
Granulocyte-Macrophage Colony-Stimulating Factor
1
Fluorodeoxyglucose F18
1
Exercise
1
Crizotinib
1
Carmustine
1
Biopsy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Uveal Melanoma
×
aldesleukin
×
Clear all
NCT07063875
2025-07-14
SILVER
St Vincent's Hospital, Sydney
Phase 1/2
Recruiting
8 enrolled